These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 203217)

  • 1. Factors concerning the immunity to poxvirus infection.
    Tagaya I; Arita M; Amano H; Ueda Y
    Ann Microbiol (Paris); 1977 Oct; 128(3):409-16. PubMed ID: 203217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences between extracellular and intracellular forms of poxvirus and their implications.
    Boulter EA; Appleyard G
    Prog Med Virol; 1973; 16():86-108. PubMed ID: 4356899
    [No Abstract]   [Full Text] [Related]  

  • 3. A poxvirus of primates. II. Immunology.
    Nicholas AH
    J Natl Cancer Inst; 1970 Nov; 45(5):907-14. PubMed ID: 18605416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies on reactivation in Poxvirus group. IV. Reactivation of so-called hot mutant of heat-inactivated vaccinia virus by so-called active cold mutant in Hep-2 cell culture at 41 degrees C].
    Mazur B
    Med Dosw Mikrobiol; 1970; 22(3):257-67. PubMed ID: 5483150
    [No Abstract]   [Full Text] [Related]  

  • 5. Reproduction of vaccinia virus (strain neurolapina) in rabbit blood leucocytes in vitro.
    Benda R; Cinátl J; Plaisner V
    J Hyg Epidemiol Microbiol Immunol; 1975; 19(1):93-104. PubMed ID: 165236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of resistance to influenza virus infection in animal models.
    Potter CW; McLaren C; Jennings R
    Dev Biol Stand; 1975; 28():307-18. PubMed ID: 1126574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poxvirus-based Japanese encephalitis vaccine candidates induce JE virus-specific CD8+ cytotoxic T lymphocytes in mice.
    Konishi E; Kurane I; Mason PW; Shope RE; Ennis FA
    Virology; 1997 Jan; 227(2):353-60. PubMed ID: 9018134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of the 51chromium release test to demonstrate antigenic differences between extracellular and intracellular forms of vaccinia virus.
    Balachandran N; Seth P; Mohapatra LN
    J Gen Virol; 1979 Oct; 45(1):65-72. PubMed ID: 521807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin reactions to vaccinia virus infection in the rabbits immunized with vaccinia-soluble early antigen.
    Yuasa T; Chino F; Tsuruhara T
    Jpn J Med Sci Biol; 1983 Jun; 36(3):147-56. PubMed ID: 6195379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of skin resistance to vaccinia virus in rabbits by vaccinia-soluble early antigens.
    Ueda Y; Tagaya I
    J Exp Med; 1973 Nov; 138(5):1033-43. PubMed ID: 4744920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralizing and protective antibodies directed against vaccinia virus envelope antigens.
    Galmiche MC; Goenaga J; Wittek R; Rindisbacher L
    Virology; 1999 Feb; 254(1):71-80. PubMed ID: 9927575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pox viruses as eukaryotic cloning and expression vectors: future medical and veterinary vaccines.
    Taylor J; Paoletti E
    Prog Vet Microbiol Immunol; 1988; 4():197-217. PubMed ID: 3078866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune response in rabbits to surface components of extracellular and intracellular forms of vaccinia virus.
    Balachandran N; Seth P; Mohapatra LN
    Infect Immun; 1980 Sep; 29(3):846-52. PubMed ID: 7000705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge.
    Hooper JW; Custer DM; Schmaljohn CS; Schmaljohn AL
    Virology; 2000 Jan; 266(2):329-39. PubMed ID: 10639319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular and humoral immune responses to buffalopox virus in experimentally infected mice and rabbits.
    Kaushik AK; Pandey R
    Immunology; 1980 Sep; 41(1):153-8. PubMed ID: 6253389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additional evidence for the augmented induction of tumor-specific resistance in vaccinia virus-primed mice by immunization with vaccinia virus-modulated syngeneic tumor cells.
    Ueda S; Wakamiya N; Wu KS; Kato S; Fujiwara H; Hamaoka T
    Biken J; 1984 Mar; 27(1):1-7. PubMed ID: 6385960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune and non-immune macrophage resistance to the fibroma-myxoma virus complex.
    Tompkins WA; Rama Rao GV; Woan MC
    J Reticuloendothel Soc; 1975 Jul; 18(1):23-33. PubMed ID: 168379
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunogenicity of subviral herpes simplex virus preparations: protection of mice against intraperitoneal infection with live virus.
    Kutinová L; Vonka V; Slichtová V
    Acta Virol; 1980 Dec; 24(6):391-8. PubMed ID: 6111199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some factors determining differences in the antigenicity of vaccinia virus strains.
    Marennikova SS; Climiskjan KL; Senkman LS; Macevic GR
    Bull World Health Organ; 1972; 46(2):159-63. PubMed ID: 4537479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of protection by recombinant fowl poxvirus expressing C-terminal nucleocapsid protein of infectious bronchitis virus against challenge.
    Yu L; Liu W; Schnitzlein WM; Tripathy DN; Kwang J
    Avian Dis; 2001; 45(2):340-8. PubMed ID: 11417813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.